Claritev Corp (CTEV): Nasdaq/NYSE listing notice — MultiPlan receives NYSE deficiency notice for sub-$1.00 average stock price

Claritev Corp

Average closing price below $1.00 over 30 consecutive trading days ended March 27, 2024.
Company has six months to regain compliance; cure requires $1.00+ closing and 30-day average.
Potential cure includes reverse stock split, subject to board and stockholder approval.
Notice has no immediate impact on listing or business operations.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Claritev Corp received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

March 28, 2024, MultiPlan Corporation (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”), as the average closing price of the Company’s Class A common stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period ending March 27, 2024. The Notice has no immediate impact on the listing of the Company’s Common Stock on the NYSE, subject to the Company’s complia

View on SEC.gov

Browse all listing & compliance notices →

Claritev Corp filing history →

Source: SEC EDGAR

accession 0001793229-24-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.